S. Catone

发表

Antigenic and Molecular Characterization of Wild Type 1 Poliovirus Causing Outbreaks of Poliomyelitis in Albania and Neighboring Countries in 1996

L. Fiore, B. Ibrahimi, B. Ridolfi, 1998, Journal of Clinical Microbiology.

Distribution of IL28B Polymorphism in a Cohort of Italians and Immigrants with HCV Infection: Association with Viraemia, Stage of Fibrosis and Response to Treatment

G. Costanzo, C. Mirisola, D. Genovese, 2017, Journal of Immigrant and Minority Health.

Resistance patterns and genetic variations in patients with hepatitis C virus: emerging role of telaprevir

D. Genovese, C. Argentini, S. Catone, 2010 .

Isolation and biological characterization of 3(2H)-isoflavene-resistant and -dependent poliovirus type 2 Sabin mutants.

L. Fiore, A. Gambacorta, D. Genovese, 1999, The Journal of general virology.

Characterization of alpha-defensins plasma levels in Macaca fascicularis and correlations with virological parameters during SHIV89.6Pcy11 experimental infection.

J. Heeney, M. Ciccozzi, P. Leone, 2007, AIDS research and human retroviruses.

Role of interferon lambda 4 and ALT levels in optimising treatment of HCV for patients with low-stage fibrosis

M. Conti, D. Genovese, S. Vella, 2015 .

Surveillance of suspected poliomyelitis in Albania, 1980-1995: suggestion of increased risk of vaccine associated poliomyelitis.

L. Fiore, B. Ibrahimi, D. Genovese, 1998, Vaccine.

T cell receptor excision circles (TRECs) analysis during acute intrarectal infection of cynomolgus monkeys with pathogenic chimeric simian human immunodeficiency virus.

J. Heeney, M. Ciccozzi, I. Macchia, 2007, Virus research.

Effect of chloro-, cyano-, and amidino-substituted flavanoids on enterovirus infection in vitro.

L. Fiore, P. Tomao, D. Genovese, 1995, Antiviral research.

The woodchuck hepatitis B virus infection model for the evaluation of HBV therapies and vaccine therapies

M. Rapicetta, A. Canitano, R. Giuseppetti, 2010, Expert opinion on drug discovery.

Rapid emergence of a viral resistant mutant in WHV chronically infected woodchucks treated with lamivudine and a pre-S/S CHO-derived hepatitis B virus vaccine.

M. Rapicetta, R. Glück, S. Orobello, 2007, Vaccine.

Effect of an immunogenic complex containing WHV viral particles and non‐neutralizing anti‐HBs antibodies on the outcome of WHV infection in woodchucks

M. Rapicetta, A. Canitano, R. Giuseppetti, 2011, Journal of medical virology.

Kinetics of WHV-HDV replication in acute fatal course of woodchuck hepatitis

M. Rapicetta, S. Orobello, A. Canitano, 2008, Archives of Virology.

HBV whole-genome mutation profile in HIV-1/HBV coinfected patients in a long-term follow-up study

M. Rapicetta, F. Mazzotta, D. Genovese, 2014, Infection.

New perspectives for hepatitis B vaccines and immunization.

M. Rapicetta, A. Canitano, R. Giuseppetti, 2009, Vaccine.

T‐cell‐mediated protective efficacy of a systemic vaccine approach in cynomolgus monkeys after SIV mucosal challenge

J. Heeney, M. Ciccozzi, S. Norley, 2004, Journal of medical primatology.

Protective efficacy of a multicomponent vector vaccine in cynomolgus monkeys after intrarectal simian immunodeficiency virus challenge.

J. Heeney, M. Ciccozzi, S. Norley, 2004, The Journal of general virology.

Generation of a human immunodeficiency virus type 1 chronically infected monkey B cell line expressing low levels of endogenous TRIM5α

A. Borsetti, B. Ridolfi, C. Parolin, 2009, Journal of cellular physiology.

Hepatitis C virus core protein modulates pRb2/p130 expression in human hepatocellular carcinoma cell lines through promoter methylation

P. Matarrese, M. G. Paggi, R. Sacco, 2015, Journal of experimental & clinical cancer research : CR.